...
首页> 外文期刊>Journal of Cancer >Anti-Cervical Cancer Role of Matrine, Oxymatrine and Sophora Flavescens Alkaloid Gels and its Mechanism
【24h】

Anti-Cervical Cancer Role of Matrine, Oxymatrine and Sophora Flavescens Alkaloid Gels and its Mechanism

机译:苦参碱,氧缺碱和槐花生物碱凝胶及其机理的抗宫颈癌作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Cervical cancer is one of the leading severe malignancies throughout the world. Sophra flavescens alkaloid (SFA) gels, a compound Traditional Chinese Medicine, has been clinically used in China for many years. Its individual active ingredients are matrine and oxymatrine, which has been showed that they can restrain primary tumorigenesis, while the underlying molecular mechanisms of SFA gels in cervical cancer cells remain unclear. Methods: To detect the effect of SFA gels and its active ingredients, CCK-8 assay and colony assay were used on cervical cancer cells proliferation. Transwell assay was used to detect cancer cell migration. Apoptosis and cell cycle arrest were used to detect whether SFA gels effect the cervical cancer cells proliferation. Western blot was used to detect whether SFA gels regulate the cervical cancer cells via the suppression of AKT/mTOR signaling pathway. Results: SFA gels can restrain cervical cancer cell proliferation, inhibit metastasis, induce cell cycle arrest in G2/M phase, induce cellular apoptosis through stimulation of Bax and E-cadherin, and suppression of Bcl-2, cyclin A, MMP2. Further study shows that SFA gels may regulate the cervical cancer cells via the suppression of AKT/mTOR signaling pathway. Conclusions: SFA gels, like its active ingredients, can restrain cervical cancer cells proliferation, suppress cervical cancer cell migration, induce the apoptosis and cell cycle arrest in cervical cancer cells. SFA gels may be a potential anti-tumor therapeutic agent for treating cervical cancer.
机译:背景:宫颈癌是全世界领先的严重恶性之一。 Sophra Flavescens生物碱(SFA)凝胶是一种复合中药,已在中国临床使用多年。其各种活性成分是苦参碱和氧缺碱,这已经表明它们可以抑制原发性肿瘤发生,而SFA凝胶在宫颈癌细胞中的潜在分子机制仍不清楚。方法:检测SFA凝胶及其活性成分的效果,CCK-8测定和菌落测定用于宫颈癌细胞增殖。 Transwell测定用于检测癌细胞迁移。凋亡和细胞周期停滞用于检测SFA凝胶是否影响宫颈癌细胞增殖。 Western印迹用于检测SFA凝胶是否通过抑制AKT / MTOR信号通路调节宫颈癌细胞。结果:SFA凝胶可以抑制宫颈癌细胞增殖,抑制转移,诱导G2 / M相中的细胞周期停滞,通过刺激Bax和E-cadherin诱导细胞凋亡,抑制Bcl-2,细胞周期蛋白A,MMP2。进一步的研究表明,SFA凝胶可以通过抑制AKT / MTOR信号传导途径调节宫颈癌细胞。结论:SFA凝胶,如其活性成分,可抑制宫颈癌细胞增殖,抑制宫颈癌细胞迁移,诱导宫颈癌细胞中的细胞凋亡和细胞周期停滞。 SFA凝胶可以是治疗宫颈癌的潜在抗肿瘤治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号